Sonrotoclax (BGB-11417)

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Near Add Your Location

Huntsman Cancer Institute
University of Utah
Salt Lake City, UT
  • Accepting patients
  • Show Principal Investigator
John Theurer Cancer Center at Hackensack University Medical Center 
Hackensack Meridian Health
Hackensack, NJ
  • Accepting patients
Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Accepting patients
Memorial Sloan Kettering Basking Ridge
Basking Ridge, NJ
  • Not currently accepting
  • Show Principal Investigator
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients
Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
  • Accepting patients
University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Accepting patients
Memorial Sloan Kettering Westchester
West Harrison, NY
  • Not currently accepting
  • Show Principal Investigator
Weill Cornell
New York, NY
  • Accepting patients
University of Chicago Medicine
Comprehensive Cancer Center
Chicago, IL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.